Back

Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination

2021-04-05 allergy and immunology Title + abstract only
View on medRxiv
Show abstract

While evidence for pre-existing SARS-CoV-2-cross-reactive CD4+ T cells in unexposed individuals is increasing, their functional significance remains unclear. Here, we comprehensively determined SARS-CoV-2-cross-reactivity and human coronavirus-reactivity in unexposed individuals. SARS-CoV-2-cross-reactive CD4+ T cells were ubiquitous, but their presence decreased with age. Within the spike glycoprotein fusion domain, we identified a universal immunodominant coronavirus-specific peptide epitope (...

Predicted journal destinations